Derek A. Persons

5.9k total citations · 1 hit paper
74 papers, 4.7k citations indexed

About

Derek A. Persons is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Derek A. Persons has authored 74 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 47 papers in Genetics and 25 papers in Genetics. Recurrent topics in Derek A. Persons's work include Virus-based gene therapy research (46 papers), CRISPR and Genetic Engineering (25 papers) and RNA Interference and Gene Delivery (22 papers). Derek A. Persons is often cited by papers focused on Virus-based gene therapy research (46 papers), CRISPR and Genetic Engineering (25 papers) and RNA Interference and Gene Delivery (22 papers). Derek A. Persons collaborates with scholars based in United States, Germany and Canada. Derek A. Persons's co-authors include Arthur W. Nienhuis, Phillip W. Hargrove, Hideki Hanawa, James A. Allay, Esther R. Allay, Brian P. Sorrentino, Richard A. Ashmun, Olivera J. Finn, Andrew Wilber and Josef Priller and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Derek A. Persons

73 papers receiving 4.6k citations

Hit Papers

Targeting gene-modified hematopoietic cells to the centra... 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek A. Persons United States 37 2.9k 1.8k 1.1k 754 692 74 4.7k
Dietmar Pfeifer Germany 37 2.2k 0.8× 733 0.4× 685 0.6× 742 1.0× 762 1.1× 128 6.6k
Eugenio Montini Italy 38 3.9k 1.3× 2.9k 1.6× 361 0.3× 1.2k 1.6× 279 0.4× 74 5.2k
David Vetrie United Kingdom 32 3.1k 1.1× 1.1k 0.6× 1.2k 1.0× 407 0.5× 1.1k 1.5× 59 5.7k
Dimitris Kioussis United Kingdom 52 3.9k 1.3× 1.4k 0.8× 335 0.3× 1.2k 1.6× 617 0.9× 111 9.5k
Michael L. Mucenski United States 33 3.0k 1.0× 830 0.5× 275 0.2× 601 0.8× 767 1.1× 47 5.0k
Kei Tashiro Japan 36 2.6k 0.9× 795 0.4× 346 0.3× 1.7k 2.2× 365 0.5× 105 6.4k
Dominic Cosgrove United States 37 1.7k 0.6× 492 0.3× 364 0.3× 355 0.5× 440 0.6× 84 4.5k
Bernhard Gentner Italy 29 2.7k 0.9× 1.0k 0.5× 278 0.2× 1.1k 1.5× 343 0.5× 80 4.1k
Susanne Heck United States 24 1.0k 0.3× 547 0.3× 337 0.3× 297 0.4× 818 1.2× 46 3.4k
Yutaka Hanazono Japan 30 1.9k 0.7× 1.0k 0.6× 493 0.4× 660 0.9× 395 0.6× 113 3.1k

Countries citing papers authored by Derek A. Persons

Since Specialization
Citations

This map shows the geographic impact of Derek A. Persons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek A. Persons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek A. Persons more than expected).

Fields of papers citing papers by Derek A. Persons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek A. Persons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek A. Persons. The network helps show where Derek A. Persons may publish in the future.

Co-authorship network of co-authors of Derek A. Persons

This figure shows the co-authorship network connecting the top 25 collaborators of Derek A. Persons. A scholar is included among the top collaborators of Derek A. Persons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek A. Persons. Derek A. Persons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Hui, Allistair Abraham, Yoon‐Sang Kim, et al.. (2017). Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-Thalassemia. Molecular Therapy. 25(3). 593–605. 5 indexed citations
2.
Chambers, Christopher B., Yin‐Yuan Mo, Donald S. Torry, et al.. (2016). Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death. Blood Cells Molecules and Diseases. 58. 57–66. 21 indexed citations
3.
Chambers, Christopher B., Yin‐Yuan Mo, Donald S. Torry, et al.. (2016). Data in support of transcriptional regulation and function of Fas-antisense long noncoding RNA during human erythropoiesis. Data in Brief. 7. 1288–1295. 5 indexed citations
4.
Abraham, Allistair, Yoon‐Sang Kim, Huifen Zhao, R. Keith Humphries, & Derek A. Persons. (2016). Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2rγnull Mice by Lentiviral Expression of NUP98-HOXA10HD. PLoS ONE. 11(1). e0147059–e0147059. 6 indexed citations
5.
Kasow, Kimberly A., Vanessa Morales-Tirado, David Wichlan, et al.. (2011). Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. Clinical Immunology. 141(2). 169–176. 24 indexed citations
6.
Persons, Derek A. & Christopher Baum. (2011). Solving the Problem of γ-Retroviral Vectors Containing Long Terminal Repeats. Molecular Therapy. 19(2). 229–231. 23 indexed citations
7.
Hunter, Michael J., Huifen Zhao, Laura M. Tuschong, et al.. (2011). Gene Therapy for Canine Leukocyte Adhesion Deficiency with Lentiviral Vectors Using the Murine Stem Cell Virus and Human Phosphoglycerate Kinase Promoters. Human Gene Therapy. 22(6). 689–696. 18 indexed citations
8.
Lebensburger, Jeffrey D., et al.. (2010). Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model. Haematologica. 95(9). 1599–1603. 54 indexed citations
9.
Rosch, Jason W., Angela R. Boyd, Ernesto Hinojosa, et al.. (2010). Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease. Journal of Clinical Investigation. 120(2). 627–635. 95 indexed citations
10.
Persons, Derek A.. (2010). The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in β‐thalassemia patients. Annals of the New York Academy of Sciences. 1202(1). 69–74. 14 indexed citations
12.
Soulas, Caroline, Robert E. Donahue, Cynthia E. Dunbar, et al.. (2009). Genetically Modified CD34+ Hematopoietic Stem Cells Contribute to Turnover of Brain Perivascular Macrophages in Long-Term Repopulated Primates. American Journal Of Pathology. 174(5). 1808–1817. 46 indexed citations
13.
Hargrove, Phillip W., Hideki Hanawa, John C. Obenauer, et al.. (2008). Globin Lentiviral Vector Insertions Can Perturb the Expression of Endogenous Genes in β-thalassemic Hematopoietic Cells. Molecular Therapy. 16(3). 525–533. 90 indexed citations
14.
Pestina, Tamara I., et al.. (2008). Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin. Molecular Therapy. 17(2). 245–252. 83 indexed citations
15.
Ryu, Byoung Y., Derek A. Persons, Marguerite V. Evans‐Galea, John T. Gray, & Arthur W. Nienhuis. (2007). A chromatin insulator blocks interactions between globin regulatory elements and cellular promoters in erythroid cells. Blood Cells Molecules and Diseases. 39(3). 221–228. 24 indexed citations
16.
Persons, Derek A. & John F. Tisdale. (2004). Gene therapy for the hemoglobin disorders. Seminars in Hematology. 41(4). 279–286. 27 indexed citations
17.
Hematti, Peiman, Cole Ferguson, Rima Adler, et al.. (2004). Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells. PLoS Biology. 2(12). e423–e423. 209 indexed citations
18.
Allay, James A., Derek A. Persons, Phillip W. Hargrove, et al.. (1999). High-Efficiency Transduction and Long-Term Gene Expression with a Murine Stem Cell Retroviral Vector Encoding the Green Fluorescent Protein in Human Marrow Stromal Cells. Human Gene Therapy. 10(7). 1163–1173. 98 indexed citations
19.
Persons, Derek A., Michele G. Mehaffey, Michael Kaleko, Arthur W. Nienhuis, & Elio F. Vanin. (1998). An Improved Method for Generating Retroviral Producer Clones for Vectors Lacking a Selectable Marker Gene. Blood Cells Molecules and Diseases. 24(2). 167–182. 74 indexed citations
20.
Finn, Olivera J., et al.. (1991). Retroviral transduction of protein kinase C-gamma into cytotoxic T lymphocyte clones leads to immortalization with retention of specific function. The Journal of Immunology. 146(4). 1099–1103. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026